Nataliya Voloshyná

How Does Fingolimod (Gilenya®) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis?

Franz Fazekas, Ovidiu Băjenaru, Thomas Berger et al. · Frontiers in Neurology · 2013 · 25 citations · Full text

Natalizumab improves ambulation in relapsing−remitting multiple sclerosis: results from the prospective <scp>TIMER</scp> study and a retrospective analysis of <scp>AFFIRM</scp>

Nataliya Voloshyná, Eva Havrdová, Michael Hutchinson et al. · European Journal of Neurology · 2014 · 16 citations · Full text

Modern Experience of Pharmacotherapeutic Use and Effectiveness of Endolumbal Administration of Glucocorticoids in Progressive Types of Course for Multiple Sclerosis

Vitaliy Vasylovskyy, Tetiana Nehreba, Maksym Chernenko et al. · SSP Modern Pharmacy and Medicine · 2024 · 16 citations · Full text

Neurological Disorder, Clinical Neurology, Neurological Progress +16

Application of Glucocorticoids in Therapy of Multiple Sclerosis

Vitaliy Vasylovskyy, Tetiana Nehreba, Nataliya Voloshyná et al. · SSP Modern Pharmacy and Medicine · 2024 · 15 citations · Full text

Clinical Disorders, Autoimmune Disease, Neurological Disorder +12

Modern Pulse Corticosteroid Therapy in Patients with Multiple Sclerosis: Adverse Events and Clinical and Pharmacological Measures to Eliminate Them

Maksym Chernenko, Tetiana Nehreba, Nataliya Voloshyná et al. · SSP Modern Pharmacy and Medicine · 2025 · 15 citations · Full text